// App-Quantinova.ai

2778 : Use of Tyrosine Kinase Inhibitors Post-Allogeneic Stem Cell Transplant in Patients with Philadelphia or BCR-ABL Positive Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis

Researchers

Presenter

  • Elena Liew

Principal Investigators

  • Sunita Ghosh

  • Lalit Saini

Medical Centers

  • Department of Medical Oncology and Alberta Health Services-Cancer Control, University of Alberta, Edmonton, AB, Canada

  • Division of Hematology, University of Alberta, Edmonton, AB, Canada

  • University of Alberta, Division of Hematology, Department of Medicine, Edmonton, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved